EUVIMEDEUVIMED entdecken
Crossref

A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer

Yuko Kawai, Aiko Nagayama, Kazuhiro Miyao, Makoto Takeuchi, Takamichi Yokoe, Tomoe Kameyama, Xinyue Wang, Tomoko Seki, Maiko Takahashi, Tetsu Hayashida, Yuko Kitagawa

Breast Cancer · 2025

DOI: 10.1007/s12282-024-01641-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer, 2025. Verfasst von Yuko Kawai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, 160-8582, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Drug Resistance, Neoplasm, CRISPR-Cas Systems, Cyclin-Dependent Kinase 4. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, School of Medicine, Keio University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDrug Resistance, NeoplasmCRISPR-Cas SystemsCyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6PiperazinesPyridinesXenograft Model Antitumor AssaysProtein Kinase InhibitorsHumansFemaleAnimalsMiceMCF-7 CellsGene Knockout TechniquesNerve Tissue Proteins

Stichwörter der Autor:innen

Breast cancerCDK4/6 inhibitorsCRISPR/Cas9 genome editingDrug resistanceSEMA3F

Substanzen

Cyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6PiperazinespalbociclibPyridinesProtein Kinase InhibitorsCDK4 protein, humanCDK6 protein, humanNerve Tissue Proteins

Autor:innen und Institutionen

  • Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, 160-8582, Japan.
  • Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, 160-8582, Japan. anagayama@keio.jp.
  • Department of Surgery, Keio University Graduate School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, 160-8582, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • School of Medicine, Keio University

Zitieren

APA

Kawai, Y., Nagayama, A., Miyao, K., Takeuchi, M., Yokoe, T., Kameyama, T., Wang, X., Seki, T., Takahashi, M., Hayashida, T., & Kitagawa, Y. (2025). A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer. Breast Cancer. https://doi.org/10.1007/s12282-024-01641-y

Vancouver

Kawai Y, Nagayama A, Miyao K, Takeuchi M, Yokoe T, Kameyama T, et al. A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer. Breast Cancer. 2025. doi:10.1007/s12282-024-01641-y

BibTeX
@article{Kawai2025,
  author = {Kawai, Yuko and Nagayama, Aiko and Miyao, Kazuhiro and Takeuchi, Makoto and Yokoe, Takamichi and Kameyama, Tomoe and Wang, Xinyue and Seki, Tomoko and Takahashi, Maiko and Hayashida, Tetsu and Kitagawa, Yuko},
  title = {A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer},
  journal = {Breast Cancer},
  year = {2025},
  doi = {10.1007/s12282-024-01641-y}
}
Kostenlos starten →